Enfusion, Inc (ENFN) reported Q3 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $39.2 million versus the consensus estimate of $38.59 million.
GUIDANCE:
Enfusion, Inc sees FY2022 revenue of $149.3-150.3 million, versus the consensus of $150.7 million.